These results underscore the therapeutic potential of allotopic <i>ND4</i> expression and highlight the critical importance of MTS optimization for developing effective treatments for mitochondrial diseases like LHON. The gene discussed is MT-ND4; the disease is inborn mitochondrial metabolism disorder.